Delaware
|
001-37415
|
32-0454912
|
||
(State or other jurisdiction
of incorporation)
|
(Commission File Number)
|
(I.R.S. Employer Identification No.)
|
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
☐
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
☐
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
☐
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Exhibit No.
|
|
Description |
|
|
|
●
|
certain risks and uncertainties associated with the acquisitions of New Mexico Health Connections and the acquisition of Valence Health, including future core business and premium revenues may be less than expected, the timing and extent of new lives expected to come onto the platform may not occur as expected and the expected results of Evolent may not be impacted as anticipated;
|
|
●
|
the structural change in the market for health care in the United States;
|
|
●
|
uncertainty in the health care regulatory framework;
|
|
●
|
the uncertain impact the results of the 2016 presidential and congressional elections may have on health care laws and regulations;
|
|
●
|
our ability to effectively manage our growth;
|
|
●
|
the significant portion of revenue we derive from our largest partners, and the potential loss, termination or renegotiation of customer contracts;
|
|
●
|
our ability to offer new and innovative products and services;
|
|
●
|
risks related to completed and future acquisitions, investments and alliances, which may be difficult to integrate, divert management resources, result in unanticipated costs or dilute our stockholders;
|
|
●
|
the growth and success of our partners, which is difficult to predict and is subject to factors outside of our control, including premium pricing reductions and the ability to control and, if necessary, reduce health care costs;
|
|
●
|
our ability to attract new partners and deliver results for partners, our ability to identify and complete strategic merger and acquisition opportunities and our ability to invest capital with attractive economics;
|
|
●
|
the increasing number of risk-sharing arrangements we enter into with our partners;
|
|
●
|
our ability to recover the significant upfront costs in our partner relationships;
|
|
●
|
our ability to estimate the size of our target market;
|
|
●
|
our ability to maintain and enhance our reputation and brand recognition;
|
|
●
|
consolidation in the health care industry;
|
|
●
|
competition which could limit our ability to maintain or expand market share within our industry;
|
|
●
|
our ability to partner with providers due to exclusivity provisions in our contracts;
|
|
●
|
restrictions and penalties as a result of privacy and data protection laws;
|
|
●
|
adequate protection of our intellectual property, including trademarks;
|
|
●
|
any alleged infringement, misappropriation or violation of third-party proprietary rights;
|
|
●
|
our use of “open source” software;
|
|
●
|
our ability to protect the confidentiality of our trade secrets, know-how and other proprietary information;
|
|
●
|
our reliance on third parties and licensed technologies;
|
|
●
|
our ability to use, disclose, de-identify or license data and to integrate third-party technologies;
|
|
●
|
data loss or corruption due to failures or errors in our systems and service disruptions at our data centers;
|
|
●
|
online security risks and breaches or failures of our security measures;
|
|
●
|
our reliance on Internet infrastructure, bandwidth providers, data center providers, other third parties and our own systems for providing services to our users;
|
|
●
|
our reliance on third-party vendors to host and maintain our technology platform;
|
|
●
|
our dependency on our key personnel, and our ability to attract, hire, integrate and retain key personnel;
|
|
●
|
the risk of potential future goodwill impairment on our results of operations;
|
|
●
|
our indebtedness and our ability to obtain additional financing;
|
|
●
|
our ability to achieve profitability in the future;
|
|
●
|
the requirements of being a public company;
|
|
●
|
our adjusted results may not be representative of our future performance;
|
|
●
|
the risk of potential future litigation;
|
|
●
|
our holding company structure and dependence on distributions from Evolent Health LLC;
|
|
●
|
our obligations to make payments to certain of our pre-IPO investors for certain tax benefits we may claim in the future;
|
|
●
|
our ability to utilize benefits under the tax receivables agreement described herein;
|
|
●
|
our ability to realize all or a portion of the tax benefits that we currently expect to result from past and future exchanges of Class B common units of Evolent Health LLC for our Class A common stock, and to utilize certain tax attributes of Evolent Health Holdings and an affiliate of TPG;
|
|
●
|
distributions that Evolent Health LLC will be required to make to us and to the other members of Evolent Health LLC;
|
|
●
|
our obligations to make payments under the tax receivables agreement that may be accelerated or may exceed the tax benefits we realize;
|
|
●
|
different interests among our pre-IPO investors, or between us and our pre-IPO investors;
|
|
●
|
the terms of agreements between us and certain of our pre-IPO investors;
|
|
●
|
the potential volatility of our Class A common stock price;
|
|
●
|
the potential decline of our Class A common stock price if a substantial number of shares become available for sale or if a large number of Class B common units are exchanged for shares of Class A common stock;
|
|
●
|
provisions in our second amended and restated certificate of incorporation and amended and restated by-laws and provisions of Delaware law that discourage or prevent strategic transactions, including a takeover of us;
|
|
●
|
the ability of certain of our investors to compete with us without restrictions;
|
|
●
|
provisions in our second amended and restated certificate of incorporation which could limit our stockholders’ ability to obtain a favorable judicial forum for disputes with us or our directors, officers or employees;
|
|
●
|
our intention not to pay cash dividends on our Class A common stock;
|
|
●
|
our ability to remediate the material weakness in our internal control over financial reporting; and
|
|
●
|
our lack of public company operating experience.
|
EVOLENT HEALTH, INC.,
|
|||
|
By:
|
/s/ Jonathan Weinberg | |
Name: Jonathan Weinberg | |||
Title: General Counsel and Secretary | |||
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end
(-2;1M-NM
M0C42/:6\TRHQ(#&.-G"DCD D8)'-7"/-*,-KM+[V)NROV*GA'6W\1Z/9ZK*B
MPO>0),R*254N,X!."0/4BJJ1]G.4%T;0)W29CV?BV:Y\577AHQ(L-K8Q7:S!
MCO9I'52A7&T 9SD'-6Z:5)5;ZN35O0F^O+Y'=5SEA0!R'CWQ++X0T2YUB"-9
MY+81D1NQ56WRI&
MU]HE>+BHR3TNK)/_ (!*C96ZWNB[=:9XZUZ)=-O)[#2X-R>?>V$EP;J1%()$
M"LJ"!I,?,Q8X!('&5,J5"'OQ4I/I&27*O6V]AVD]-%Z'13>%KIO%5IKJ,AM+
M739;-@S,9C(\H=6^Z0R[1\S%PV[L>M9*HE2E2ZN2EY62';6_D.O?#%U<>*[3
MQ C1BUM;">V=26\TR2R!E*KMVE<#DE@<] :%42I2I:W ^ #/7QGI[ R+YIA$?F>9Y3[<;RN.F0>"W.!CON^6@!$\;:8>'=XVR^%:-\
MD*[*I )/FA"T8 RP[ \4 2OXQTV'B5WB.<8>*1#P65R RC(C9'60C.UEQW&
M0!DOC/3X6 /FE"&;?Y4@3:IVA@2HRKOE$*64Y(&"0#0N]?MK(1,^\K<(7C
M")(SL %.!&JEONDDYQC'(] "I>>*;:RG2%DE9'C27S4C9D".DSAN 2<+"Q;C
MY0 Y ,8^ &$;QBY!W@ L\;,2N.=V9=OR<
M&(J%90-I;!)+ FM/!UNSR%9X9G R6$:F1)&,;*Y( 9*IB3$TI
MGE1;E\_(4RK*GEC!#1H=X7]YM=B =1JFC:C=&,03;66!(_-,LB%)%W>8_EH
MH27SP54EMIBV[T&3BD L6F:@J7EQ/(5FFB<0)'+)((2?,.%#"-2W,8#!0 ]A_P"%
M'Y_FSGEN:E=5R I % "5H2+0 4 % !0 4#1W_P *O^1LTS_KX/\ Z)EKFK_P
MY>GZHN.Z/T+KYTZ0H * "@ H :[!%+'HH)_+F@#R_P#X3RZE%';K$O+!I'
MW.,(X\L[!SM<(=P&'(XY I@:7_":2+<-:/' CK@&1IG6%&'WQ([1 KD_+&0I
M#,0.A!H M1>)KG[!%=^5%))*UR659&"JD'F.0"8RQD*(% *K\QR<#BD!GKX^
M8*9)+5A&&X*N&90I+R"15!*21P)+,5.,E-@Y.: -2^\5/8-")(D'F0).Z&4B
M3#MMVQH(R9#'G?)TVH&(!H Q_P#A-[F6(3Q0PA(GQ*6E;Y\K,56(^7@%O* R
MW\3!0ISPP)Y_&MQ:S/;/:J9(=ZMB7"LPWE3'N0.\8V 2$(2I;H, :5KXG,
MD5Y+/'&DFGY!VNSJ1EA]\1G +1Y( +J,;T4@90&?#XTFEC$OV>-8]XA+F4A5
MD8R?O&_=D+ HB+.^2RJ0=I )+ 6X\4W,&FQ7 $/G3B=@Y8A#Y4P14A&W][(Z
ML#&IV;U1FR* *B^-KB9T=(-J N60.K,5 1\$@$I)&F_?&0"6V@$ZERI+=1M;1]Q$KJ/Q9>:^
M[1_8[O3H[155F\X.KJS$C;M"X!P0Y.<<5JZB]E&DKW4F_+45O>;\CF/#7AKQ
M=X1L_P"P-._LMK.-Y/)OI#,)E21V?=);*FV69=W!,P1B &) K6'Q"
M"'C98_,D01S/ORH4OM*N&+,L2]\N 2,@L2 2[M$M)6TE]J&'YFWN0"UVKHP+
M%]S.ZEMQ.0 P^8$B@"(VOA[4KQU!CEN KS/ME? "$JSMAPH*ESM/!&=R] 0;
M 268T"RE6X@FC61M[9:X<[S\Y>1P[G>_,GSN"V,@' & !MGIFE7*PWMLVVWM
M[@LI9F8&2,R0QA6D9BD:222%$3"EVS@=" 5M6E\/H[27+AFN%=CY
MNG>9'$4,#2,ZJJA=CL3O7 .T 8'0 [BV12 P=9\,C4KN2:1XH(6BB4-L!DW)
MY^Y0Q90L;"4"1<'S -N5&:8%%_ *[I2DJ8D\T*KQ%U592YR5,H3S(M^(754"
M*,%2&.$!.G@TVKK*DL+M#-]H1I8 9-^/N&7?E8E'*!0"K
8XHMOFR$LZ@[0Z_*I+-DX!P: ,)?&D4VPP
M6TS$LF\OLC"12,@#Y=ANR'! 7C((8C&2P&1^-K8G,<,IVJQ*J(]RK&K2.V[S
M I41C< I)+' SF@"WK6M6]E
KB3>T0"JBF=VB;+_ZAC+B1=P#(N#C.5 +C>%X=1L8[9)H
MR(3<%7B0;%>9V?Y%#G8(]Q3 ;=L) 92
5M#':"25&12 GEM-5B@LC$UR7BA>.Y > R$EX
7M&_."RYVT ;
M>E+JMO=%+YII8"L>'/D<2%5+ B,9*9,FY\(5PJ[6!#4@,^?3]:BGN;BS>7?O
M/DK(\31,K/(W0Y8+&K+L&4(?@[E&* $U"\U73]+229Y5F,L@RB1>>1LD,"D$
MR1SO8%,:W'F.\8A:4I&X#0EU0[@\<1+LH(WR*8Q@E12 DN-8U**W@D2,E
MW68G%O*QE='"PQ[ P-OYZ$R;I21%C:W0Y ,^75M;EAD\ARVE5R-TJ;]Q8K&\:I',%=4^5A(1YFT-DDL " &R&!9;Q5-;6MI*\:RR7,"S,-Q0N24
M7RX%VMYDF7W[?E^12>_" O:=XE_M*=DB1/(BA$KR"0MR8XWV*%0@E6=E8[LC
M;]TDD YN+QW-.[%8XPBQ_<$AWNS%"&A!C^@). @%/C:TC81
M-!./E60 *C_N6VE)<(S8!W+\APZ\Y' RP'/XS@B57DMITWD)'D1,6>1(I$0!
M)&(W1RHQ)&T8*D[@ 0!LGC*+Y?)MIF$KJOS>6A)(B:0;2^[>B2KPP <@J#@
MD N_\)5:K8#4'CD$9=HC& I=9%5BL94-P\A 1%.#O=%(&